Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr27 Inhibitors

Olr27 inhibitors represent a specific class of chemical compounds that interact with the olfactory receptor 27 (Olr27), a member of the G protein-coupled receptor (GPCR) family. This receptor is primarily found in the olfactory epithelium and is involved in the detection of odorant molecules, contributing to the sensory perception of smell. The inhibition of Olr27 involves compounds that bind to the receptor in a manner that blocks or modulates its normal interaction with endogenous ligands, thereby preventing or altering signal transduction pathways within olfactory sensory neurons. The structural characteristics of Olr27 inhibitors are diverse, often containing specific moieties that allow for high affinity and selective binding to the Olr27 receptor. The design and synthesis of these inhibitors can involve complex molecular frameworks, including heterocyclic structures, aromatic rings, and various functional groups that enhance receptor binding and specificity.

In the context of chemical research, Olr27 inhibitors are of significant interest for understanding the fundamental mechanisms of olfactory signal transduction. By inhibiting the Olr27 receptor, researchers can dissect the role of this specific receptor in olfaction, potentially identifying key residues and conformational changes involved in ligand binding and receptor activation. Moreover, these inhibitors serve as valuable tools in the broader study of GPCR function, providing insights into the structural dynamics and signal modulation across different receptor types. The development of Olr27 inhibitors often involves the use of computational modeling, high-throughput screening, and structure-activity relationship (SAR) studies, allowing for the fine-tuning of chemical properties to achieve desired levels of potency and selectivity. This chemical class continues to be a focus in olfactory research, contributing to the broader understanding of sensory perception and the molecular intricacies of GPCR-mediated signaling pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Amlodipine

88150-42-9sc-200195
sc-200195A
100 mg
1 g
$74.00
$166.00
2
(1)

Calcium channel blocker, can indirectly affect GPCR signaling by altering calcium dynamics, potentially impacting Olr27.

Carvedilol

72956-09-3sc-200157
sc-200157A
sc-200157B
sc-200157C
sc-200157D
100 mg
1 g
10 g
25 g
100 g
$124.00
$240.00
$530.00
$999.00
$1530.00
2
(1)

Beta-adrenergic receptor antagonist, may modulate GPCR signaling, potentially influencing Olr27.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$91.00
$139.00
$374.00
36
(1)

Glucocorticoid, could indirectly affect GPCR signaling through genomic mechanisms, impacting Olr27.

Hydrochlorothiazide

58-93-5sc-207738
sc-207738A
sc-207738B
sc-207738C
sc-207738D
5 g
25 g
50 g
100 g
250 g
$55.00
$240.00
$333.00
$562.00
$988.00
(0)

Diuretic, could affect GPCR signaling indirectly through alterations in electrolyte balance, impacting Olr27.

Ipratropium bromide

22254-24-6sc-203606
100 mg
$85.00
3
(0)

Muscarinic receptor antagonist, might modulate GPCR signaling pathways, potentially affecting Olr27.

Losartan

114798-26-4sc-353662
100 mg
$130.00
18
(1)

Angiotensin II receptor antagonist, can indirectly modulate GPCR signaling, potentially impacting Olr27.

Metformin

657-24-9sc-507370
10 mg
$79.00
2
(0)

Biguanide, could influence GPCR signaling indirectly via metabolic pathways, impacting Olr27.

Omeprazole

73590-58-6sc-202265
50 mg
$67.00
4
(1)

Proton pump inhibitor, may indirectly affect GPCR signaling through altered gastric pH, potentially impacting Olr27.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Non-selective beta-adrenergic receptor antagonist, can alter GPCR signaling, potentially impacting Olr27.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Calcium channel blocker, might influence GPCR signaling through calcium modulation, potentially impacting Olr27.